OPRX
OptimizeRx Corp · Services · Market cap $176.5M
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$19K
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Latest filing
Oct 2, 2026
Stelmakh Edward
OptimizeRx Corp (OPRX) has 39 SEC Form 4 filings (48 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Oct 2, 2026.
Inside the rolling window, 1 insider at OptimizeRx Corp reported no open-market purchases and 1 open-market sale totaling $19K. The most recent open-market filing is a sale of 1,388 shares by Chief Finance & Strat Officer Stelmakh Edward, dated Dec 19, 2025, worth $19K.
- Industry:Medical - Healthcare Information Services
- CEO:Stephen L. Silvestro
- Employees:133
- HQ:Waltham, MA, US
- IPO:2007-11-28
| Source | |||||||
|---|---|---|---|---|---|---|---|
Stelmakh EdwardFirst filing | Chief Finance & Strat Officer | Sale | 1,388 | $19K | Dec 22 | -29.5% | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does OPRX have?
OptimizeRx Corp (OPRX) has 39 SEC Form 4 filings (48 transaction rows) in the rolling 365-day window, disclosed by 1 distinct insider. Most recent filing: Oct 2, 2026.
When was the most recent SEC Form 4 filing for OPRX?
The most recent Form 4 filing for OPRX on Tracefour is dated Oct 2, 2026.
What is the total insider buy and sell value at OPRX in the current window?
Inside the rolling window, insiders at OPRX bought $0 and sold $19K based on SEC Form 4 filings.
Can I get alerts for OPRX insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at OptimizeRx Corp (OPRX). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
OptimizeRx Corp is in the Services sector.